NPPB and chronic kidney disease: Natriuretic peptides, including B-type natriuretic peptide (BNP) and N-terminal pro B-type natriuretic peptide (NT-proBNP), are commonly used biomarkers for the diagnosis and management of acute and chronic HF, and have also been shown to predict CV risk in patients with CKD [151].